Consultative
An Extension of Your Team
Receive expert planning, guidance, and data interpretation directly from the scientists running your experiments.
Elevating the standard for data quality and scientific partnership
0+
Years
0+
Clients worldwide
0+
Projects per year
0+
Citations
Reaction Biology delivers reliable, timely data that moves novel therapeutics forward, helping reduce risk at every milestone
Pharmaceutical, biotech, and academic teams partner with us to advance compounds from early discovery through clinical development, guided by rigorous quality standards and gold-standard methodologies.
Across four sites across North America and Europe, our expertise spans multiple modalities, target classes, and therapeutic areas.
Our expansive target library and panel selection includes hundreds of validated proteins and over 1,000 cell lines, plus the industry’s largest kinase library.
Since 2001, we have turned complex scientific challenges into development-ready candidates, supporting hundreds of oncology programs towards IND.
Qualities driving our exceptional track record
An Extension of Your Team
Receive expert planning, guidance, and data interpretation directly from the scientists running your experiments.
Matching Your Speed and Rigor
Avoid surprises and mitigate risk with proactive communication from our dedicated teams. Responses to new requests within 24 hours and rapid quoting.
25 Years of Expertise
Our validated, gold-standard methodologies and deep scientific expertise have advanced novel therapies toward IND across oncology, metabolic disease, and other critical indications
End-to-end drug discovery workflows
Comprehensive enzyme and protein target profiling
Physiologically relevant cellular models and phenotypic screening
Molecular interaction characterization providing critical binding kinetics, thermodynamics, and selectivity data
Regulatory-compliant bioanalytical testing and quality control services
Comprehensive safety profiling from early liability assessment to GLP toxicology studies
Diverse preclinical efficacy models and translational pharmacology studies
Specialized immune-oncology platform supporting next generation cancer immunotherapies
Multi-platform biomarker identification and validation services
Tailored drug discovery solutions and specialized assay development